User Fee Conference Committee Targets Settling Differences In June
This article was originally published in The Tan Sheet
Executive Summary
A conference committee tackles differences between House and Senate FDA user fee and agency reform bills, with an agreement expected before the end of June.
You may also be interested in...
Bipartisan Support Pushes FDA User Fee Bill One Step From Passage
The Senate is expected to vote this week on the bipartisan compromise of the FDA user fee and reform legislation, which the House overwhelmingly passed in a voice vote June 20. Senate review of the bill will coincide with the Supreme Court’s decision on the health care reform law.
Bipartisan Support Pushes FDA User Fee Bill One Step From Passage
The Senate is expected to vote this week on the bipartisan compromise of the FDA user fee and reform legislation, which the House overwhelmingly passed in a voice vote June 20. Senate review of the bill will coincide with the Supreme Court’s decision on the health care reform law.
Foreign Regulatory Systems Can Be Strengthened By Receiving FDA Inspection Data, IOM Says
Institute of Medicine report recommends how FDA, industry and other stakeholders can strengthen food and drug regulatory systems abroad. It calls for FDA to provide incentives for foreign regulators to meet U.S. standards and facilitate training and for the government to help hold importers liable.